Two Sigma Securities »

Protalix Biotherapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $61k 52k 1.17
2024-03-31 $108k 85k 1.26
2023-12-31 $79k 45k 1.78
2023-06-30 $31k 15k 2.00
2023-03-31 $44k 21k 2.10

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Protalix Biotherapeutics

Renaissance Technologies
Goldman Sachs Group
GSA Capital Partners
BlackRock
Stratos Wealth Partners
Bridgeway Capital Management
BlackRock
Citadel Advisors
Squarepoint Ops
Qube Research & Technologies
Morgan Stanley
Susquehanna International
Orin Green Financial
Two Sigma Securities
Northern Trust

View all funds holding Protalix Biotherapeutics